Navigation Links
FDA Approves 'Bionic Eye' to Help Against Rare Vision Disorder
Date:2/15/2013

r testified. "It was the first time I was able to see letters on the monitor screen [during a test of visual perception]. I had not seen letters since 1994, so that was huge."

A third person said he had a 17-year-old son, "and I don't mind telling you how much -- I mean, how happy that made me, not only to see the silhouette of my son, but to hear that voice coming and saying, 'Yeah, it's me, Dad. I'm here and I love you.'"

People with retinitis pigmentosa suffer damage to the light-sensitive cells of the retina. As these cells slowly degenerate, patients lose side vision and night vision and later on, central vision. The disease can cause blindness,

The FDA's approval is a limited one, labeled a "humanitarian use device" approval, meaning the Argus II can be used only for fewer than 4,000 patients per year.

The FDA is currently restricting approval to people aged 25 years and older who have severe retinitis pigmentosa and can see light but not identify its source. Eligible patients also include those who cannot see light, but who have some retinal function and a history of being able to see forms.

In addition, patients must be willing and able to get the recommended follow-up, device fitting and visual rehabilitation, the agency said.

Dr. Robert Greenberg, president and CEO of Second Sight Medical Products Inc., the maker of the device, said that "patients with retinitis pigmentosa in the United States for the first time ever will [now] have a treatment option."

Greenberg said the device does not restore full vision, but does give patients what he calls "low vision," meaning it lets them perform visual tasks that they couldn't otherwise do.

This is only the first step, Greenberg added. "One of the great things about the Argus II system is that it is a software-driven system," he said, and "we expect to be producing software upgrades for all the implanted patients."

Current lab work suggests those upgrades will i
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. MSSD Approves of the Encinitas School District’s Holistic Education
2. FDA Approves 3 New Drugs for Type 2 Diabetes
3. FDA Approves 1st Skin Patch to Combat Migraines
4. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
5. FDA Approves New Type of Flu Vaccine
6. FDA Approves New Once-a-Day HIV Pill
7. FDA Approves Flu Vaccine for Coming Season
8. FDA Approves 2nd New Weight-Loss Drug
9. FDA Approves 1st Pill to Help Prevent HIV Infection
10. FDA Approves First New Weight-Loss Drug in More Than a Decade
11. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves 'Bionic Eye' to Help Against Rare Vision Disorder
(Date:10/1/2014)... for holiday gift ideas? Éminence Organic Skin Care, the leader ... holiday season. Starting October 1st 2014, new spa gift sets ... Choose from two luxury skin care gift sets made from ... or to deliver whole body beauty. , The luxurious ... are formulated to suit all skin types and will tick ...
(Date:10/1/2014)... October 01, 2014 QueenBeeTickets.com is giving music ... the singer’s upcoming North American tour, which has him traveling ... come. , Click here to view the selection ... performer’s newest album, is due to come out on October ... shortly thereafter. Bob Seger concert tickets are available for shows ...
(Date:9/30/2014)... no genetic evidence that high levels of vitamin D ... Some previous research had suggested that elevated levels ... diabetes, raising the possibility of a link between vitamin ... this study, British researchers investigated the association between diabetes ... control blood levels of vitamin D. They found no ...
(Date:9/30/2014)... damaging "brain tsunamis" in injured patients without opening ... reality, thanks to pioneering research at the University ... team, led by Jed Hartings, PhD, research associate ... UC College of Medicine, has shown that spreading ... like tsunami wavescan be measured by the placement ...
(Date:9/30/2014)... Symposia will convene the first conference of its 2014-2015 ... Series on "The Modes of Action of Vaccine ... the conclusion of the Grand Challenges Meeting for that ... Keystone Symposia Global Health Series, supported by the Bill ... awards for 36 investigators from developing countries to attend. ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 2Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 3Health News:Bob Seger Presale Tickets: QueenBeeTickets.com Delights Fans with Discounted Tickets for All 20 Stops on Seger’s “Ride Out” Tour with The Silver Bullet Band 2Health News:Gene Study Finds No Proof Vitamin D Guards Against Type 2 Diabetes 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 2Health News:Researchers show EEG's potential to reveal depolarizations following TBI 3Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2
... neck pain by spine manipulation appears of little use as ... in the UK to relieve many different types of pain,// ... ,When 16 studies were reviewed it was concluded ... is effective for treating any medical problem. ...
... member of the parliament belonging to the Papua New Guinea parliament ... virus//. He will be the first person in the country to ... unnamed MP could be jailed under a 2003 law that made ... Nation newspaper in Papua New Guinea reported. ,The paper ...
... became known that they had cheated the Medicare by more ... were not mandated and hence was never conducted. ... of the illegal scheme from 1997 to 2005. He and ... beneficiaries and introducing them to several doctor’s and medical labs ...
... (FSA), that the daily intake of salt should be limited to ... mention the amount of salt content in their food labels. A ... either side. ,A public awareness watchdog for Foodstuffs set ... salt in a lot of food products. This is done for ...
... common man that how official failings led to a man ... history of violence. Stuart Robertson was killed by James Smith, ... in October 2004. This report mainly gives us an insight ... , There was a failure to respond adequately ...
... the first of its kinds study conducted by the ... Communications Research (CECCR) found// that Women suffering from breast ... given the opportunity to participate in online support groups. ... to ,openly express themselves trying to make sense of ...
Cached Medicine News:Health News:Research demystifies treatment by manipulation of spine by chiropractors in the UK 2Health News:Salt & Its Intake Causes a Strong debate In UK 2Health News:Study Finds Online Support Groups Emotionally Benefit Women Suffering From 2
(Date:9/30/2014)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced ... Officer, will present at the Stem Cell Meeting on ... 7, 2014, at 5:00PM Pacific Daylight Time. ...
(Date:9/30/2014)... 2014 Arbor Pharmaceuticals, LLC. - Product ... Markets Direct,s, ,Arbor Pharmaceuticals, LLC. - Product Pipeline ... Arbor Pharmaceuticals, LLC.,s pharmaceutical research and development focus. ... current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.,s, ... assessment by drug target, mechanism of action (MoA), ...
(Date:9/30/2014)... Sept. 30, 2014  According to their CEO, ... cancer clinical trials is going through a complete ... the work of the current clinical trial management ... ,next generation, clinical trials, which will ultimately drive ... The company has been recognized by the ...
Breaking Medicine Technology:MiMedx to Present at the Stem Cell Meeting on the Mesa 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
... Today GenVec, Inc. (Nasdaq: GNVC ) announced financial ... 2010.  For the year ended December 31, 2010, the Company ... share, compared with a net loss of $18.4 million, or ... GenVec ended the year with $35.2 million in cash, cash ...
... RIVER EDGE, N.J., March 10, 2011 Nephros, Inc. ... device company developing and marketing filtration products for therapeutic ... completion of its rights offering and private placement that ... to Nephros.  The aggregate net proceeds received by Nephros ...
Cached Medicine Technology:GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 2GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 3GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 4GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 5GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 6GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 7GenVec Reports Fourth Quarter and 2010 Year-End Financial Results 8Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions 2Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions 3Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: